Scilex Holding Company (SCLX)
NASDAQ: SCLX · Real-Time Price · USD
0.448
+0.007 (1.64%)
At close: Dec 20, 2024, 4:00 PM
0.449
+0.002 (0.34%)
After-hours: Dec 20, 2024, 6:41 PM EST

Scilex Holding Company Revenue

Scilex Holding Company had revenue of $16.37M in the quarter ending June 30, 2024, with 30.11% growth. This brings the company's revenue in the last twelve months to $50.83M, up 9.41% year-over-year. In the year 2023, Scilex Holding Company had annual revenue of $46.74M with 22.90% growth.

Revenue (ttm)
$50.83M
Revenue Growth
+9.41%
P/S Ratio
1.01
Revenue / Employee
$484,124
Employees
105
Market Cap
58.95M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202346.74M8.71M22.90%
Dec 31, 202238.03M6.72M21.45%
Dec 31, 202131.32M7.76M32.92%
Dec 31, 202023.56M2.53M12.01%
Dec 31, 201921.03M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Outset Medical 114.73M
Atara Biotherapeutics 100.44M
Repare Therapeutics 66.52M
Apyx Medical 48.54M
BioAtla 11.00M
Kronos Bio 9.86M
Milestone Scientific 8.88M
Pheton Holdings 572.29K
Revenue Rankings

SCLX News

More News